Streetbeat News

Revenues

AWI

Armstrong World Industries (NYSE:AWI) received mixed analyst ratings, with a shift from bullish to indifferent in the last 30 days. Analysts from UBS, Evercore ISI Group, Goldman Sachs, and Truist Securities raised their price targets, reflecting a positive outlook on AWI's financial performance, including revenue growth, net margin, and ROE, despite a high debt-to-equity ratio. The average 12-month price target for AWI is now $126, up from $111, indicating a 13.51% increase.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 4:01 pm

SKT

Recent analyst ratings for Tanger (NYSE:SKT) show a mix of perspectives, with an average 12-month price target of $29.8, indicating a 7.97% increase from the previous target. The ratings reflect adjustments based on market conditions and company performance, with actions ranging from 'Lowers' to 'Raises'. Tanger's financial performance includes a revenue growth rate of 9.46%, a net margin of 18.4%, and an ROE of 4.44%, despite challenges in debt management and asset utilization.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 4:00 pm

ECL

Ecolab (NYSE:ECL) has received mixed analyst ratings over the past three months, with a consensus leaning towards a neutral stance. The recent evaluations from 20 analysts show a shift towards more indifferent ratings in the last 30 days. The average 12-month price target for Ecolab is now $238.65, marking a 9.44% increase from the previous target of $218.06. This adjustment reflects analysts' optimism about Ecolab's financial performance, including a notable revenue growth rate of 7.28% and a strong net margin of 10.29%. However, concerns are raised due to Ecolab's high debt-to-equity ratio of 1.09.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 4:00 pm

TM

Toyota Motor North America announced a 13.7% increase in U.S. vehicle sales for April 2024, totaling 211,818 vehicles.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 3:13 pm

APD

Analysts have recently updated their ratings and price targets for Air Products & Chemicals (NYSE:APD), showing a mix of bullish and neutral stances. Over the past quarter, 10 analysts offered diverse opinions, with the latest 12-month price targets ranging from $240.00 to $295.00, averaging $265.6, down from the previous $291.00. The company, a leading industrial gas supplier, reported a revenue decline of -5.58% for the last quarter but maintains strong financial health indicators such as a 20.33% net margin and a 4.18% ROE.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 3:02 pm

ASH

Analysts have updated their ratings and price targets for Ashland (NYSE:ASH), showing a positive outlook with an average 12-month price target of $116, up from $100.33, indicating a 15.62% increase. The updates include raised price targets from Mizuho, Wells Fargo, and Jefferies, reflecting bullish to somewhat bullish sentiments. Despite facing a -9.9% revenue decline and challenges in market capitalization and ROE, Ashland's strong net margin and ROA, along with a low debt-to-equity ratio, suggest a solid financial foundation.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 3:01 pm

TREE

Recent analyst ratings for LendingTree (NASDAQ:TREE) show a predominantly bullish outlook, with 9 analysts offering perspectives ranging from bullish to indifferent. Over the last three months, there has been a noticeable shift towards more positive ratings. The average 12-month price target for TREE has been raised to $45.89, marking a 51.85% increase from the previous target of $30.22. This adjustment reflects analysts' growing optimism about LendingTree's future performance, despite the company facing revenue challenges and a high debt-to-equity ratio. LendingTree's strong net margin and ROE indicate effective cost control and financial performance.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 3:00 pm

ETN

Eaton Corp (NYSE:ETN) received mixed ratings from 14 analysts, with a shift towards more bullish perspectives in recent months. The average 12-month price target is $318.64, marking a 17.85% increase from the previous target. Eaton's financial performance shows strong profitability and effective cost control, with a notable revenue growth rate of 10.83% and a net margin of 15.84%. The company's market capitalization and financial metrics like ROE and ROA exceed industry averages, indicating a robust market position and financial health.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 3:00 pm

NVO

Denmark's healthcare authority has decided to prioritize prescribing less expensive drugs over GLP-1 drugs like Novo Nordisk's Ozempic for type 2 diabetes patients. This decision, aimed at cost-effectiveness, could lead to nearly half of all current GLP-1 drug users switching to cheaper alternatives, despite the popularity of drugs like Ozempic for their weight-loss benefits. The change will take effect from Nov. 25, impacting Novo Nordisk's (NYSE:NVO) market for Ozempic and Rybelsus, as well as Eli Lilly's Trulicity.

Portfolio Pulse from Benzinga Neuro

May 01, 2024 | 2:44 pm

PRCT

PROCEPT BioRobotics projects its FY24 revenue to be $213.5 million, surpassing the estimated $210.178 million.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 2:42 pm